The UK NEQAS for Blood Coagulation Clinical and Laboratory Haemostasis meeting will return to Sheffield Hallam University on 5-6 June. This annual scientific and scheme participants' meeting attracts speakers and delegates from across the UK and abroad; and meeting reports are a regular feature of Pathology in Practice content.
The first day’s programmes will cover the following: The future of gene therapy for patients with haemophilia (John Pasi, Royal London Hospital); Haemophilia patients with inhibitors: novel therapies (Peter Lenting, INSERM, University Paris-Sud, Paris); Challenges of haemophilia care in childhood and adolescence (Mary Mathias, Great Ormond Street Hospital, London); Diagnostic algorithm for von Willebrand disease (Sandra Haberichter, Blood Centre of Wisconsin, USA); Laboratory criteria for antiphospholipid syndrome (Katrien Devreese, Gent University Hospital, Gent, Belgium); Recognition and meaning of lupus anticoagulant (Vittorio Pengo, Department of Cardiothoracic & Vascular Sciences, Padova, Italy); Coagulation reference ranges in children (Pierre Toulon, Université Nice Sofia-Antipolis, France); and a debate of the motion ‘It was better in the ‘olden’ days’ (Will Lester, Queen Elizabeth Hospital, Birmingham, UK, and Mike Greaves (University of Aberdeen, UK).
The programme for the second day will include: Managing cancer associated thrombosis (Simon Noble, Cardiff University, UK); PNH-associated thrombosis (Anita Hill, St James' University Hospital, Leeds, UK); Bloodless surgery (Aryeh Shander, Clinical Care & Hyperbaric Medicine, Englewood Hospital, USA); Trauma-induced coagulopathy (Dr Ross Davenport, Queen Mary University of London); The Manchester Arena attack: impact on the hospital team (Martin Smith, Salford Royal Foundation Trust, UK); D-dimer diagnostics: real-life implementation challenges (Rita Selby, University Health Network & Sunnybrook HSC, Toronto, Canada); Coagulation testing: sample suitability and rejection criteria (Dot Adcock Funk, Esoterix Coagulation, Denver, USA); and Networking coagulation testing: logistic considerations (Giuseppe Lippi, University of Verona, Italy)
www.neqascoag.org
